| 000 | 01814 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515090324.0 | ||
| 264 | 0 | _c20071101 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a1079-5006 | ||
| 024 | 7 |
_a10.1093/gerona/62.9.943 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Xuping | |
| 245 | 0 | 0 |
_aGlial cell-derived neurotrophic factor protects against proteasome inhibition-induced dopamine neuron degeneration by suppression of endoplasmic reticulum stress and caspase-3 activation. _h[electronic resource] |
| 260 |
_bThe journals of gerontology. Series A, Biological sciences and medical sciences _cSep 2007 |
||
| 300 |
_a943-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aEndoplasmic Reticulum _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
| 650 | 0 | 4 |
_aGlial Cell Line-Derived Neurotrophic Factor _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInclusion Bodies _xdrug effects |
| 650 | 0 | 4 |
_aNerve Degeneration _xmetabolism |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aParkinson Disease _xmetabolism |
| 650 | 0 | 4 | _aProteasome Inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
| 700 | 1 | _aPeng, Changgeng | |
| 700 | 1 | _aLi, Liang | |
| 700 | 1 | _aMing, Ming | |
| 700 | 1 | _aYang, Dehua | |
| 700 | 1 | _aLe, Weidong | |
| 773 | 0 |
_tThe journals of gerontology. Series A, Biological sciences and medical sciences _gvol. 62 _gno. 9 _gp. 943-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/gerona/62.9.943 _zAvailable from publisher's website |
| 999 |
_c17417968 _d17417968 |
||